Skip to main content
. Author manuscript; available in PMC: 2023 Jan 3.
Published in final edited form as: J Thorac Cardiovasc Surg. 2020 May 5;163(2):629–641.e7. doi: 10.1016/j.jtcvs.2020.04.100

TABLE E2.

Percentage of patients estimated to be alive and have experienced first ATA recurrence (CIF), dead before ATA recurrence (CIF), or alive and free from ATA recurrence (composite end point) at each year following the CMP-IV

Year First ATA recurrence (CIF) Death (CIF) Alive and free from any ATA (composite end point) Number at risk

1 11% 3% 87% 633
2 15% 3% 82% 539
3 18% 6% 76% 459
4 21% 6% 73% 390
5 23% 8% 69% 318
6 26% 9% 65% 256
7 29% 9% 62% 207
8 30% 9% 61% 157
9 32% 10% 58% 117
10 35% 11% 58% 88

Also see Figure 2. ATA, Atrial tachyarrhythmia; CIF, cumulative incidence function.